Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Melanocortin Receptor Selective Ligands
NATIONAL INSTITUTES OF HEALTH (NIH)
7/1/21 → 4/30/25
Project: Research project
-
Chemical biology of Peptide Regulation of Opioid Receptor Function
Haskell-Luevano, C. & Portoghese, P. S.
5/1/20 → 2/28/25
Project: Research project
-
Discovery of Opioid Receptor Endogenous Allosteric Modul
WINSTON & MAXINE WALLIN NEURO DISC FUND
1/1/18 → 12/31/18
Project: Research project
-
Novel Melanocortin Receptor Probe Discovery
NIH NATL INST OF DIABETES/DIG/KIDNEY DIS
4/1/16 → 3/31/21
Project: Research project
-
Defensins as Melanocortin Ligands
NIH NATL INST OF DIABETES/DIG/KIDNEY DIS
10/1/15 → 11/30/17
Project: Research project
-
Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2′)-Orn-NH2] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2′)-Arg-NH2]
Ericson, M. D., Tran, L. T., Mathre, S. S., Freeman, K. T., Holdaway, K., John, K., Lunzer, M. M., Bouchard, J. L. & Haskell-Luevano, C., Jun 22 2023, In: Journal of medicinal chemistry. 66, 12, p. 8103-8117 15 p.Research output: Contribution to journal › Article › peer-review
-
Erratum: Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High Throughput 'Unbiased' Screening Campaign (J. Med. Chem. (2021) 64:9 (5577−5592) DOI: 10.1021/acs.jmedchem.0c02041)
Doering, S. R., Freeman, K., Debevec, G., Geer, P., Santos, R. G., Lavoi, T. M., Giulianotti, M. A., Pinilla, C., Appel, J. R., Houghten, R. A., Ericson, M. D. & Haskell-Luevano, C., May 25 2023, In: Journal of medicinal chemistry. 66, 10, p. 7063-7065 3 p.Research output: Contribution to journal › Comment/debate › peer-review
-
The Parallel Structure–Activity Relationship Screening of Three Compounds Identifies the Common Agonist Pharmacophore of Pyrrolidine Bis-Cyclic Guanidine Melanocortin-3 Receptor (MC3R) Small-Molecule Ligands
Ericson, M. D., Freeman, K. T., LaVoi, T. M., Donow, H. M., Santos, R. G., Giulianotti, M. A., Pinilla, C., Houghten, R. A. & Haskell-Luevano, C., Jun 2023, In: International journal of molecular sciences. 24, 12, 10145.Research output: Contribution to journal › Article › peer-review
Open Access -
Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide
Ericson, M. D., Larson, C. M., Freeman, K. T., Nicke, L., Geyer, A. & Haskell-Luevano, C., Aug 9 2022, In: ACS Omega. 7, 31, p. 27656-27663 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Development of hMC1R Selective Small Agonists for Sunless Tanning and Prevention of Genotoxicity of UV in Melanocytes
Koikov, L., Starner, R. J., Swope, V. B., Upadhyay, P., Hashimoto, Y., Freeman, K. T., Knittel, J. J., Haskell-Luevano, C. & Abdel-Malek, Z. A., Jul 1 2021, In: Journal of Investigative Dermatology. 141, 7, p. 1819-1829 11 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations